Portage Biotech Inc (NASDAQ:PRTG) has a beta value of 101.26 and has seen 0.59 million shares traded in the recent trading session. The company, currently valued at $1.54M, closed the recent trade at $0.12 per share which meant it lost -$0.03 on the day or -22.89% during that session. The PRTG stock price is -2483.33% off its 52-week high price of $3.10 and -8.33% below the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.19 million shares traded. The 3-month trading volume is 909.92K shares.
The consensus among analysts is that Portage Biotech Inc (PRTG) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Portage Biotech Inc (NASDAQ:PRTG) trade information
Sporting -22.89% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PRTG stock price touched $0.12 or saw a rise of 30.52%. Year-to-date, Portage Biotech Inc shares have moved -93.63%, while the 5-day performance has seen it change -26.72%. Over the past 30 days, the shares of Portage Biotech Inc (NASDAQ:PRTG) have changed -35.61%. Short interest in the company has seen 60582.0 shares shorted with days to cover at 0.04.
Wall Street analysts have a consensus price target for the stock at $19.5, which means that the shares’ value could jump 99.38% from the levels at last check today. The projected low price target is $18.0 while the price target rests at a high of $21.0. In that case, then, we find that the latest price level in today’s session is -17400.0% off the targeted high while a plunge would see the stock gain -14900.0% from the levels at last check today.
Portage Biotech Inc (PRTG) estimates and forecasts
The company’s shares have lost -80.78% over the past 6 months, compared to 17.10% for the industry.
Portage Biotech Inc (NASDAQ:PRTG)’s Major holders
Insiders own 38.82% of the company shares, while shares held by institutions stand at 10.96% with a share float percentage of 17.91%. Investors are also buoyed by the number of investors in a company, with Portage Biotech Inc having a total of 29.0 institutions that hold shares in the company. The top two institutional holders are ARMISTICE CAPITAL, LLC with over 1.67 million shares worth more than $0.94 million. As of 2024-03-31, ARMISTICE CAPITAL, LLC held 7.9719% of shares outstanding.
The other major institutional holder is BISON WEALTH, LLC, with the holding of over 0.21 million shares as of 2024-03-31. The firm’s total holdings are worth over $0.12 million and represent 1.0212% of shares outstanding.
